PDS Biotechnology Corp
General ticker "PDSB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $74.9M
PDS Biotechnology Corp does not follow the US Stock Market performance with the rate: -20.1%.
Estimated limits based on current volatility of 3.5%: low 1.64$, high 1.81$
Factors to consider:
- Current price 47.8% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.20$, 7.72$]
- 2024-12-30 to 2025-12-30 estimated range: [2.94$, 7.23$]
Financial Metrics affecting the PDSB estimates:
- Negative: Non-GAAP EPS, $ of -1.38 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -17.30 <= 2.35
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Interest expense per share, $ of 0.14 <= 0.14
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Investing cash flow per share, $ of 0 > -0.12
Short-term PDSB quotes
Long-term PDSB plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $21.44MM | $41.67MM | $43.05MM |
| Operating Income | $-21.44MM | $-41.67MM | $-43.05MM |
| Non-Operating Income | $0.00MM | $-0.38MM | $-1.30MM |
| Interest Expense | $0.00MM | $1.32MM | $4.21MM |
| R&D Expense | $11.25MM | $29.43MM | $27.76MM |
| Income(Loss) | $-21.43MM | $-42.05MM | $-44.35MM |
| Taxes | $-4.52MM | $-1.20MM | $-1.41MM |
| Profit(Loss) | $-16.92MM | $-40.85MM | $-42.94MM |
| Stockholders Equity | $63.21MM | $44.00MM | $26.13MM |
| Assets | $67.20MM | $77.01MM | $59.39MM |
| Operating Cash Flow | $-12.49MM | $-25.71MM | $-33.64MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $48.89MM | $34.29MM | $16.38MM |
| Earnings Per Share* | $-0.66 | $-1.43 | $-1.39 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.